Skip to content

Tectonic Therapeutics TECX Net Change in Cash

Net Change in Cash at other companies

ALN
Alnylam PharmaceuticalsALNY
$53.61M0.0%
Septerna, Inc. logo
Septerna, Inc.SEPN
-$49.12M-74.5%
Regenxbio logo
RegenxbioRGNX
-$19.24M-127%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$431K-86.7%
Opko Health logo
Opko HealthOPK
-$27.18M-769%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-$23.7M+90.5%

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$585.51M+58.3%
Enterprise value$353.51M+438%

Returns & leverage

See full
Return on equity-31.4%
Debt / equity0.0×
Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tectonic Therapeutics's net change in cash?
Tectonic Therapeutics (TECX) reported net change in cash of -$17.49M in Q1 2026.
How has Tectonic Therapeutics's net change in cash changed year-over-year?
Tectonic Therapeutics's net change in cash decreased by 110.6% year-over-year, from $165.01M to -$17.49M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.